Literature DB >> 12393653

T lymphocytes constitutively produce an interferonlike cytokine limitin characterized as a heat- and acid-stable and heparin-binding glycoprotein.

Kenji Oritani1, Seiichi Hirota, Taishirou Nakagawa, Isao Takahashi, Shin-Ichiro Kawamoto, Masahide Yamada, Naoko Ishida, Toshihiko Kadoya, Yoshiaki Tomiyama, Paul W Kincade, Yuji Matsuzawa.   

Abstract

Several reports have described "multifunctional" eukaryotic mRNAs producing more than one protein through alternative translational initiation at multiple AUG codons. There are 2 such codons in the 5' region of our recently cloned limitin gene where 2 open reading frames overlap by 34 nucleotides. The deduced protein translated from the first ATG contains 33 amino acids, lacks a signal peptide, and has no obvious effects on the transfected 293T cells. We found that the second ATG is more effective as a translational initiation site than the first ATG and yields a secreted protein of 182 amino acids with the same activity as products made with full-length limitin cDNA. Immunohistochemical and reverse transcription-polymerase chain reaction analysis revealed that the longer limitin protein is produced by mature T lymphocytes in spleen and thymus as well as by bronchial epithelial and salivary duct cells in healthy mice. Properties of recombinant limitin were determined, revealing it to be a serologically distinct, heat- and acid-stable, heparin-binding glycoprotein with the potential for dimerization. Although the longer limitin protein is structurally and characteristically related to type I interferons, its production is uniquely regulated by translation as well as transcription.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393653     DOI: 10.1182/blood-2002-01-0045

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Good's syndrome, CVID, and selective antibody deficiency in patients with chronic rhinosinusitis.

Authors:  Marianne Frieri
Journal:  Curr Allergy Asthma Rep       Date:  2014-06       Impact factor: 4.806

Review 2.  Interferon-zeta/limitin: novel type I interferon that displays a narrow range of biological activity.

Authors:  Kenji Oritani; Yoshiaki Tomiyama
Journal:  Int J Hematol       Date:  2004-11       Impact factor: 2.490

3.  The role of alternative translation start sites in the generation of human protein diversity.

Authors:  Alex V Kochetov; Akinori Sarai; Igor B Rogozin; Vladimir K Shumny; Nikolay A Kolchanov
Journal:  Mol Genet Genomics       Date:  2005-06-15       Impact factor: 3.291

4.  Antiviral activity of limitin against encephalomyocarditis virus, herpes simplex virus, and mouse hepatitis virus: diverse requirements by limitin and alpha interferon for interferon regulatory factor 1.

Authors:  Shin-Ichiro Kawamoto; Kenji Oritani; Hideo Asada; Isao Takahashi; Jun Ishikawa; Hitoshi Yoshida; Masahide Yamada; Naoko Ishida; Hidetoshi Ujiie; Hiroaki Masaie; Yoshiaki Tomiyama; Yuji Matsuzawa
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 5.  Cytokines and microRNAs in SARS-CoV-2: What do we know?

Authors:  Fahimeh Zamani Rarani; Bahman Rashidi; Mohammad Hassan Jafari Najaf Abadi; Michael R Hamblin; Seyed Mohammad Reza Hashemian; Hamed Mirzaei
Journal:  Mol Ther Nucleic Acids       Date:  2022-06-25       Impact factor: 10.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.